Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Change in Accured Expenses: 2010-2025

Historic Change in Accured Expenses for Solesence (SLSN) over the last 15 years, with Sep 2025 value amounting to -$849,000.

  • Solesence's Change in Accured Expenses fell 160.21% to -$849,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 0.43%. This contributed to the annual value of $4.0 million for FY2024, which is 2831.51% up from last year.
  • Solesence's Change in Accured Expenses amounted to -$849,000 in Q3 2025, which was down 196.26% from $882,000 recorded in Q2 2025.
  • In the past 5 years, Solesence's Change in Accured Expenses ranged from a high of $1.6 million in Q4 2024 and a low of -$849,000 during Q3 2025.
  • Its 3-year average for Change in Accured Expenses is $390,364, with a median of $419,000 in 2025.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first slumped by 1,266.67% in 2021, then soared by 734.36% in 2024.
  • Quarterly analysis of 5 years shows Solesence's Change in Accured Expenses stood at -$310,000 in 2021, then decreased by 4.52% to -$324,000 in 2022, then rose by 20.06% to -$259,000 in 2023, then skyrocketed by 734.36% to $1.6 million in 2024, then slumped by 160.21% to -$849,000 in 2025.
  • Its Change in Accured Expenses stands at -$849,000 for Q3 2025, versus $882,000 for Q2 2025 and $419,000 for Q1 2025.